Karyopharm Therapeutics has reached a significant milestone by completing patient enrolment for its Phase III SENTRY trial.

Revolution will now explore daraxonrasib’s potential as a monotherapy and in combination with chemotherapy in late-stage PDAC ...

In August, Regeneron announced positive results from Phase III clinical trial NIMBLE evaluating the efficacy and safety of ...

PhaseV has entered into a strategic partnership with Bioforum to enhance the efficiency of clinical trials using advanced ...

Transformative new shifts have taken place in the last month in the metabolic dysfunction-associated steatohepatitis (MASH) ...

As the IASLC 2025 World Conference on Lung Cancer approaches, CTA looks at some of the most promising NSCLC assets in Phase ...

Sanofi’s stock dropped in the wake of data from its Phase III trial of atopic dermatitis (AD) candidate amlitelimab, which ...

Takeda’s readout comes from two pivotal Phase III trials of its OX2R, with Alkermes’ data coming from a Phase II trial in NT1 ...

Alnylam has disclosed new analysis findings from the HELIOS-B Phase III clinical trial of RNA interference (RNAi) therapeutic ...

RealTime eClinical Solutions has rolled out the TrialAlign platform that aims to refine the performance analytics for ...

In this podcast, Steve Bulera discusses the current state of the animal-alternative testing space, as well as the sector's ...

Researchers at the UQ's AIBN have received approval for a trial to examine a heart medication in treating amyotrophic lateral ...